ID   HYAL4_HUMAN             Reviewed;         481 AA.
AC   Q2M3T9; D0VXG1; Q9UL99; Q9Y6T9;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 2.
DT   28-JUN-2023, entry version 132.
DE   RecName: Full=Hyaluronidase-4;
DE            Short=Hyal-4;
DE            EC=3.2.1.35;
DE   AltName: Full=Chondroitin sulfate endo-beta-N-acetylgalactosaminidase;
DE   AltName: Full=Chondroitin sulfate hydrolase;
DE            Short=CSHY;
DE   AltName: Full=Hyaluronoglucosaminidase-4;
GN   Name=HYAL4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=10493834; DOI=10.1006/geno.1999.5876;
RA   Csoka A.B., Scherer S.W., Stern R.;
RT   "Expression analysis of six paralogous human hyaluronidase genes clustered
RT   on chromosomes 3p21 and 7q31.";
RL   Genomics 60:356-361(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19889881; DOI=10.1093/glycob/cwp174;
RA   Kaneiwa T., Mizumoto S., Sugahara K., Yamada S.;
RT   "Identification of human hyaluronidase-4 as a novel chondroitin sulfate
RT   hydrolase that preferentially cleaves the galactosaminidic linkage in the
RT   trisulfated tetrasaccharide sequence.";
RL   Glycobiology 20:300-309(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-346.
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND 3D-STRUCTURE MODELING.
RX   PubMed=16104017; DOI=10.1002/prot.20592;
RA   Jedrzejas M.J., Stern R.;
RT   "Structures of vertebrate hyaluronidases and their unique enzymatic
RT   mechanism of hydrolysis.";
RL   Proteins 61:227-238(2005).
RN   [8]
RP   GLYCOSYLATION AT ASN-177.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
CC   -!- FUNCTION: Endo-hyaluronidase that degrades hyaluronan to smaller
CC       oligosaccharide fragments. Has also chondroitin sulfate hydrolase
CC       activity, The best substrate being the galactosaminidic linkage in the
CC       sequence of a trisulfated tetrasaccharide.
CC       {ECO:0000269|PubMed:16104017, ECO:0000269|PubMed:19889881}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Random hydrolysis of (1->4)-linkages between N-acetyl-beta-D-
CC         glucosamine and D-glucuronate residues in hyaluronate.; EC=3.2.1.35;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 4.5-5 (for chondroitin sulfate hydrolase activity).
CC         {ECO:0000269|PubMed:19889881};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius.
CC         {ECO:0000269|PubMed:19889881};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in placenta and skeletal muscle.
CC       {ECO:0000269|PubMed:10493834}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 56 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF009010; AAC98883.1; -; mRNA.
DR   EMBL; AB470346; BAI49593.1; -; mRNA.
DR   EMBL; AC006029; AAD43186.1; -; Genomic_DNA.
DR   EMBL; CH236947; EAL24331.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83603.1; -; Genomic_DNA.
DR   EMBL; BC104788; AAI04789.1; -; mRNA.
DR   EMBL; BC104790; AAI04791.1; -; mRNA.
DR   CCDS; CCDS5789.1; -.
DR   RefSeq; NP_036401.2; NM_012269.2.
DR   RefSeq; XP_011514292.1; XM_011515990.2.
DR   RefSeq; XP_016867400.1; XM_017011911.1.
DR   AlphaFoldDB; Q2M3T9; -.
DR   SMR; Q2M3T9; -.
DR   BioGRID; 117097; 11.
DR   IntAct; Q2M3T9; 2.
DR   MINT; Q2M3T9; -.
DR   STRING; 9606.ENSP00000223026; -.
DR   DrugBank; DB08818; Hyaluronic acid.
DR   CAZy; GH56; Glycoside Hydrolase Family 56.
DR   GlyConnect; 1382; 3 N-Linked glycans (1 site).
DR   GlyCosmos; Q2M3T9; 5 sites, 3 glycans.
DR   GlyGen; Q2M3T9; 5 sites, 3 N-linked glycans (1 site).
DR   iPTMnet; Q2M3T9; -.
DR   PhosphoSitePlus; Q2M3T9; -.
DR   BioMuta; HYAL4; -.
DR   DMDM; 158564281; -.
DR   PaxDb; Q2M3T9; -.
DR   PeptideAtlas; Q2M3T9; -.
DR   ProteomicsDB; 61382; -.
DR   Antibodypedia; 31779; 100 antibodies from 18 providers.
DR   DNASU; 23553; -.
DR   Ensembl; ENST00000223026.9; ENSP00000223026.4; ENSG00000106302.10.
DR   Ensembl; ENST00000476325.5; ENSP00000417186.1; ENSG00000106302.10.
DR   GeneID; 23553; -.
DR   KEGG; hsa:23553; -.
DR   MANE-Select; ENST00000223026.9; ENSP00000223026.4; NM_012269.3; NP_036401.2.
DR   UCSC; uc003vlc.4; human.
DR   AGR; HGNC:5323; -.
DR   CTD; 23553; -.
DR   DisGeNET; 23553; -.
DR   GeneCards; HYAL4; -.
DR   HGNC; HGNC:5323; HYAL4.
DR   HPA; ENSG00000106302; Tissue enhanced (placenta, skeletal muscle).
DR   MIM; 604510; gene.
DR   neXtProt; NX_Q2M3T9; -.
DR   OpenTargets; ENSG00000106302; -.
DR   PharmGKB; PA29574; -.
DR   VEuPathDB; HostDB:ENSG00000106302; -.
DR   eggNOG; ENOG502QPZH; Eukaryota.
DR   GeneTree; ENSGT01020000230364; -.
DR   HOGENOM; CLU_036366_0_0_1; -.
DR   InParanoid; Q2M3T9; -.
DR   OMA; AGQDINY; -.
DR   OrthoDB; 5344684at2759; -.
DR   PhylomeDB; Q2M3T9; -.
DR   TreeFam; TF321598; -.
DR   BioCyc; MetaCyc:HS02883-MON; -.
DR   BRENDA; 3.2.1.35; 2681.
DR   PathwayCommons; Q2M3T9; -.
DR   SignaLink; Q2M3T9; -.
DR   BioGRID-ORCS; 23553; 17 hits in 1143 CRISPR screens.
DR   ChiTaRS; HYAL4; human.
DR   GenomeRNAi; 23553; -.
DR   Pharos; Q2M3T9; Tbio.
DR   PRO; PR:Q2M3T9; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q2M3T9; protein.
DR   Bgee; ENSG00000106302; Expressed in triceps brachii and 80 other tissues.
DR   ExpressionAtlas; Q2M3T9; baseline and differential.
DR   Genevisible; Q2M3T9; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004415; F:hyalurononglucosaminidase activity; IBA:GO_Central.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0030207; P:chondroitin sulfate catabolic process; IEA:Ensembl.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:ProtInc.
DR   GO; GO:0030214; P:hyaluronan catabolic process; IBA:GO_Central.
DR   Gene3D; 3.20.20.70; Aldolase class I; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR018155; Hyaluronidase.
DR   PANTHER; PTHR11769; HYALURONIDASE; 1.
DR   PANTHER; PTHR11769:SF7; HYALURONIDASE-4; 1.
DR   Pfam; PF01630; Glyco_hydro_56; 1.
DR   PIRSF; PIRSF038193; Hyaluronidase; 1.
DR   PRINTS; PR00846; GLHYDRLASE56.
DR   PRINTS; PR00848; SPERMPH20.
DR   SUPFAM; SSF51445; (Trans)glycosidases; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Glycosidase; Hydrolase;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..481
FT                   /note="Hyaluronidase-4"
FT                   /id="PRO_0000301999"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..29
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..453
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        454..474
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        475..481
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        147
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        86
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        115
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        177
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19139490"
FT   CARBOHYD        343
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        59..351
FT                   /evidence="ECO:0000250"
FT   DISULFID        223..237
FT                   /evidence="ECO:0000250"
FT   DISULFID        376..387
FT                   /evidence="ECO:0000250"
FT   DISULFID        381..435
FT                   /evidence="ECO:0000250"
FT   DISULFID        437..446
FT                   /evidence="ECO:0000250"
FT   VARIANT         346
FT                   /note="A -> S (in dbSNP:rs6949082)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_034936"
FT   CONFLICT        263
FT                   /note="G -> C (in Ref. 1; AAC98883)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   481 AA;  54249 MW;  9D530009AA898D1F CRC64;
     MKVLSEGQLK LCVVQPVHLT SWLLIFFILK SISCLKPARL PIYQRKPFIA AWNAPTDQCL
     IKYNLRLNLK MFPVIGSPLA KARGQNVTIF YVNRLGYYPW YTSQGVPING GLPQNISLQV
     HLEKADQDIN YYIPAEDFSG LAVIDWEYWR PQWARNWNSK DVYRQKSRKL ISDMGKNVSA
     TDIEYLAKVT FEESAKAFMK ETIKLGIKSR PKGLWGYYLY PDCHNYNVYA PNYSGSCPED
     EVLRNNELSW LWNSSAALYP SIGVWKSLGD SENILRFSKF RVHESMRIST MTSHDYALPV
     FVYTRLGYRD EPLFFLSKQD LVSTIGESAA LGAAGIVIWG DMNLTASKAN CTKVKQFVSS
     DLGSYIANVT RAAEVCSLHL CRNNGRCIRK MWNAPSYLHL NPASYHIEAS EDGEFTVKGK
     ASDTDLAVMA DTFSCHCYQG YEGADCREIK TADGCSGVSP SPGSLMTLCL LLLASYRSIQ
     L
//
